// App-Quantinova.ai

BSH2020‐PO‐202 : Prophylactic donor lymphocyte infusion reduces the risk of relapse and increases survival in patients with mixed T cell chimerism after reduced intensity allogeneic stem cell transplantation

Researchers

Presenter

  • R. Buka

Principal Investigators

  • S. Nagra

  • P. Jenkin

  • N. Dean

  • M. Cook

  • S. Chaganti

  • R. Malladi

  • C. Craddock

Medical Centers

  • Centre for Clinical Haematology, Queen Elizabeth Hospital

  • University of Birmingham,

  • NHS Blood and Transplant, Birmingham

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Autoimmune (AI)

Disease

  • Graft-versus-host disease

  • Alpha-thalassemia myelodysplasia syndrome

  • Acute myelocytic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved